Author,Exposure,Outcome,Direction,Strength
McCarthy 2018,acute heart failure,myocardial infarction (type 2),Increase,6.0
,acute heart failure,mortality,Increase,6.84
,acute heart failure,nt-pro-BNP,Increase,6.0
,age,diabetes,Increase,4.52
,age,FIRST ISCHEMIC STROKE,Increase,6.84
,age,atrial fibrillation,Increase,4.34
"Bishop, Lu, & Yankner, 2010",age,kognitive decline,Increase,4.0
,age,atherosclerosis,Increase,6.84
Diener 2020,anticoagulation,second ischemic stroke,Decrease,3.0
Diener 2020,anticoagulation,FIRST ISCHEMIC STROKE,Decrease,3.0
,anticoagulation,cardiac thrombus,Decrease,2.72
,atherosclerosis,FIRST ISCHEMIC STROKE,Increase,6.68
,atherosclerosis,myocardial infarction (type 1),Increase,6.84
,atrial fibrillation,FIRST ISCHEMIC STROKE,Increase,6.84
,atrial fibrillation,troponin elevation,Increase,6.0
,atrial fibrillation,nt-pro-BNP,Increase,6.0
,atrial fibrillation,severe arrrhythmia,Increase,6.0
,BMI,myocardial infarction (type 1),Increase,6.84
,BMI,second ischemic stroke,Increase,6.84
,BMI,FIRST ISCHEMIC STROKE,Increase,4.34
Rizas et al 2017,cardiac autonomic dysbalance,severe arrrhythmia,Increase,4.0
,cardiac thrombus,FIRST ISCHEMIC STROKE,Increase,5.1
,chronic heart failure,kognitive decline,Increase,4.52
,chronic heart failure,FIRST ISCHEMIC STROKE,Increase,4.34
,chronic heart failure,nt-pro-BNP,Increase,3.22
,chronic heart failure,troponin elevation,Increase,6.0
,depression,higher fitness/mobility post,Decrease,2.68
,depression,mortality,Increase,2.68
Ghadri 2018,depression,Takotsubo syndrome,Increase,2.0
,diabetes,mortality,Increase,4.52
,diabetes,infection,Increase,3.22
,diabetes,myocardial infarction (type 1),Increase,6.0
,diabetes,FIRST ISCHEMIC STROKE,Increase,4.52
,diabetes,BMI,Increase,4.52
,diabetes,cardiac autonomic dysbalance,Increase,4.0
,dissection,FIRST ISCHEMIC STROKE,Increase,3.92
,dysphagia,infection,Increase,3.22
,elevated catecholamines,severe arrrhythmia,Increase,3.76
Ghadri 2018,elevated catecholamines,Takotsubo syndrome,Increase,6.0
,exercise (cardiac not excessive),hypertension,Decrease,3.92
Diener 2020,exercise (cardiac not excessive),FIRST ISCHEMIC STROKE,Decrease,4.0
Strohle et al 2015,exercise (cardiac not excessive),kognitive decline,Decrease,3.0
,exercise (cardiac not excessive),atrial fibrillation,Increase,2.52
,exercise (cardiac not excessive),myocardial infarction (type 1),Decrease,2.72
,exercise (cardiac not excessive),chronic heart failure,Decrease,3.92
Scheitz et al 2014,FIRST ISCHEMIC STROKE,troponin elevation,Increase,6.0
,FIRST ISCHEMIC STROKE,second ischemic stroke,Increase,6.84
Diener 2020,FIRST ISCHEMIC STROKE,mortality,Increase,6.0
scheitz 2018,FIRST ISCHEMIC STROKE,acute heart failure,Increase,3.0
,FIRST ISCHEMIC STROKE,higher fitness/mobility post,Decrease,4.34
,FIRST ISCHEMIC STROKE,kognitive decline,Increase,4.52
Thygesen 2018,FIRST ISCHEMIC STROKE,myocardial infarction (type 2),Increase,6.0
,FIRST ISCHEMIC STROKE,depression,Increase,4.61
"Scheitz, Templin 2021 under review",FIRST ISCHEMIC STROKE,Takotsubo syndrome,Increase,3.0
,FIRST ISCHEMIC STROKE,infection,Increase,3.22
"Scheitz et al, Sposato 2020",FIRST ISCHEMIC STROKE,elevated catecholamines,Increase,2.0
,FIRST ISCHEMIC STROKE,seizures,Increase,4.17
,FIRST ISCHEMIC STROKE,dysphagia,Increase,3.22
scheitz et al 2018,FIRST ISCHEMIC STROKE,severe arrrhythmia,Increase,6.0
,higher fitness/mobility post,second ischemic stroke,Increase,4.34
,higher fitness/mobility pre,FIRST ISCHEMIC STROKE,Decrease,4.34
,higher fitness/mobility pre,mortality,Decrease,6.0
,hyperlipidemia,myocardial infarction (type 1),Increase,6.84
,hyperlipidemia,FIRST ISCHEMIC STROKE,Increase,3.22
,hypertension,myocardial infarction (type 1),Increase,6.84
,hypertension,FIRST ISCHEMIC STROKE,Increase,5.1
,hypertension,dissection,Increase,3.92
,hypertension,chronic heart failure,Increase,5.1
Sandoval 2019,hypertension,myocardial infarction (type 2),Increase,4.0
,hypertension,acute heart failure,Increase,5.1
,infection,mortality,Increase,3.22
Sandoval 2019,infection,myocardial infarction (type 2),Increase,4.0
van der Linden 2017,kidney disease,troponin elevation,Increase,2.0
,myocardial infarction (type 1),FIRST ISCHEMIC STROKE,Increase,2.68
Rizas et al 2017,myocardial infarction (type 1),cardiac autonomic dysbalance,Increase,6.0
"thygesen et al 2018, McAloon 2016",myocardial infarction (type 1),mortality,Increase,6.0
thygesen et al 2018,myocardial infarction (type 1),severe arrrhythmia,Increase,6.0
thygesen et al 2018,myocardial infarction (type 1),troponin elevation,Increase,6.0
Thygesen 2018,myocardial infarction (type 1),acute heart failure,Increase,6.0
Thygesen 2018,myocardial infarction (type 1),cardiac thrombus,Increase,5.0
,myocardial infarction (type 1),chronic heart failure,Increase,6.84
DeFilippis 2019,myocardial infarction (type 2),troponin elevation,Increase,6.0
McCarthy et al 2018,myocardial infarction (type 2),mortality,Increase,6.0
Wiktor 2018,persistent foramen ovale,FIRST ISCHEMIC STROKE,Increase,3.0
,second ischemic stroke,mortality,Increase,6.0
,seizures,mortality,Increase,6.54
Faria et al 2020,seizures,troponin elevation,Increase,4.0
,severe arrrhythmia,mortality,Increase,6.68
,sex (male),smoking,Increase,3.84
,sex (male),FIRST ISCHEMIC STROKE,Increase,4.34
,sex (male),Takotsubo syndrome,Decrease,2.68
,smoking,FIRST ISCHEMIC STROKE,Increase,6.84
,smoking,myocardial infarction (type 1),Increase,6.84
,stroke lesion affecting central autonomic network,cardiac autonomic dysbalance,Increase,2.72
Scheitz et.al 2018 lancet,stroke lesion affecting central autonomic network,severe arrrhythmia,Increase,6.0
Krause et al 2017,stroke lesion affecting central autonomic network,troponin elevation,Increase,6.0
Scheitz 2018,stroke lesion affecting central autonomic network,elevated catecholamines,Increase,2.0
Ghadri et at 2018,Takotsubo syndrome,troponin elevation,Increase,4.0
scheitz 2014,troponin elevation,higher fitness/mobility post,Decrease,3.0
broersen et al 2020,troponin elevation,kognitive decline,Increase,4.0
